ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 121,61
0,02%
DAX
18 155,24
-0,04%
Brent Oil
84,205
0,02%
Bitcoin
61 400,80
-0,66%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) Actualités

CERE

Cerevel Therapeutics (CERE)

Cerevel Therapeutics Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CERE
DateHeureSourceTitreSymboleSociété
08/05/202422h17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERECerevel Therapeutics Holdings Inc
18/04/202412h30GlobeNewswire Inc.Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
27/02/202422h02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERECerevel Therapeutics Holdings Inc
16/02/202422h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202415h00Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CERECerevel Therapeutics Holdings Inc
09/02/202401h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
24/01/202414h30PR Newswire (US)Kuehn Law Encourages MDC, WAVD, NS and CERE Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
18/01/202413h44Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CERECerevel Therapeutics Holdings Inc
18/01/202413h19Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:CERECerevel Therapeutics Holdings Inc
05/01/202423h13Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CERECerevel Therapeutics Holdings Inc
03/01/202400h10PR Newswire (US)Kuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to Contact Law FirmNASDAQ:CERECerevel Therapeutics Holdings Inc
26/12/202323h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERECerevel Therapeutics Holdings Inc
08/12/202323h00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CERECerevel Therapeutics Holdings Inc
08/12/202312h23IH Market NewsApple Boosts Vietnam Production, Broadcom Revenue Miss, Stellantis Job Cuts – Latest UpdatesNASDAQ:CERECerevel Therapeutics Holdings Inc
07/12/202312h23IH Market NewsAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion AI Market, Chevron’s $19.5B Investment Plans, BMY Increases Dividend, and MoreNASDAQ:CERECerevel Therapeutics Holdings Inc
07/12/202305h24PR Newswire (US)CERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces Investigation Into Potential Claims Regarding AbbVie's Proposed Acquisition of Cerevel TherapeuticsNASDAQ:CERECerevel Therapeutics Holdings Inc
06/12/202322h30PR Newswire (US)AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience PipelineNASDAQ:CERECerevel Therapeutics Holdings Inc
29/11/202312h30GlobeNewswire Inc.Cerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson’s DiseaseNASDAQ:CERECerevel Therapeutics Holdings Inc
08/11/202312h30GlobeNewswire Inc.Cerevel Therapeutics to Present at Upcoming Investor ConferencesNASDAQ:CERECerevel Therapeutics Holdings Inc
01/11/202311h30GlobeNewswire Inc.Cerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business UpdatesNASDAQ:CERECerevel Therapeutics Holdings Inc
13/10/202312h30GlobeNewswire Inc.Cerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023NASDAQ:CERECerevel Therapeutics Holdings Inc
12/10/202322h16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CERECerevel Therapeutics Holdings Inc
12/10/202304h45GlobeNewswire Inc.Cerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common StockNASDAQ:CERECerevel Therapeutics Holdings Inc
11/10/202322h01GlobeNewswire Inc.Cerevel Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:CERECerevel Therapeutics Holdings Inc
29/08/202312h30GlobeNewswire Inc.Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:CERECerevel Therapeutics Holdings Inc
02/08/202312h30GlobeNewswire Inc.Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business UpdatesNASDAQ:CERECerevel Therapeutics Holdings Inc
05/07/202312h30GlobeNewswire Inc.Cerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023NASDAQ:CERECerevel Therapeutics Holdings Inc
29/06/202301h00Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CERECerevel Therapeutics Holdings Inc
15/06/202322h37Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:CERECerevel Therapeutics Holdings Inc
15/06/202312h30GlobeNewswire Inc.Cerevel Therapeutics Appoints Paul Burgess as Chief Business Development and Strategic Operations OfficerNASDAQ:CERECerevel Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CERE

Dernières Valeurs Consultées

EU
RNO
Renault
EU
PX1
CAC 40
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
COIN
ETHUSD
Ethereum
EU
GLE
Societe Generale
NYSE
MCD
McDonalds
EU
EN
Bouygues
EU
SGO
Cie de SaintGobain
EU
CAP
Capgemini
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés